Global Vitamin D Market Report 2026: Outlook on Opportunities & Challenges


 

Comments

Post a Comment

Popular posts from this blog

Thrombosis And Hemostasis Biomarkers Industry Projected to Experience Accelerated Growth by 2030

Image
 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided. What Is the Projected Growth Rate of the Thrombosis And Hemostasis Biomarkers Market Through 2030? The thrombosis and hemostasis biomarkers market size has grown strongly in recent years. It will grow from $5.17 billion in 2025 to $5.56 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to limited availability of coagulation biomarkers, reliance on manual and semi-automated analyzers, increasing prevalence of cardiovascular disorders, growing diagnostic laboratory infrastructure, rising awareness of thrombosis and he...
Read more

Viral Vector Production (Research-Use) Industry Forecasted for Rapid Expansion, Reaching $3.56 Billion by 2030

Image
The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided. What Is the Current Market Size and Growth Rate of the Viral Vectors And Plasmid DNA Market? The viral vector production (research-use) market size has grown rapidly in recent years. It will grow from $1.77 billion in 2025 to $2.04 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to increasing investment in gene therapy research, expansion of academic and translational research programs, availability of advanced cell culture technologies, rising use of viral vectors in oncology studies, growth of contract research acti...
Read more

Trastuzumab Biosimilars Industry Revenue to Reach $24.48 Billion by 2030 with CAGR of 28.9% (2026-2030)

Image
 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided. What Is the Growth Potential of the Traumatic Brain Injury Biomarkers Market in the Next Decade? The trastuzumab biosimilars market size has grown exponentially in recent years. It will grow from $6.9 billion in 2025 to $8.86 billion in 2026 at a compound annual growth rate (CAGR) of 28.5%. The growth in the historic period can be attributed to high incidence of HER2 positive breast cancer, loss of trastuzumab patent exclusivity, rising oncology drug costs, regulatory biosimilar pathways, hospital oncology adoption. The trastuzumab biosimilars market size is expected to see exponen...
Read more